rs146452560

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_002617.4(PEX10):​c.318G>A​(p.Leu106Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00968 in 1,613,844 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. L106L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0063 ( 7 hom., cov: 33)
Exomes 𝑓: 0.010 ( 98 hom. )

Consequence

PEX10
NM_002617.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.0950

Publications

2 publications found
Variant links:
Genes affected
PEX10 (HGNC:8851): (peroxisomal biogenesis factor 10) This gene encodes a protein involved in import of peroxisomal matrix proteins. This protein localizes to the peroxisomal membrane. Mutations in this gene result in phenotypes within the Zellweger spectrum of peroxisomal biogenesis disorders, ranging from neonatal adrenoleukodystrophy to Zellweger syndrome. Alternative splicing results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
PEX10 Gene-Disease associations (from GenCC):
  • peroxisome biogenesis disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • peroxisome biogenesis disorder 6A (Zellweger)
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Myriad Women’s Health, Ambry Genetics, G2P
  • peroxisome biogenesis disorder 6B
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal recessive ataxia due to PEX10 deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Zellweger spectrum disorders
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.57).
BP6
Variant 1-2408734-C-T is Benign according to our data. Variant chr1-2408734-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262789.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.095 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00634 (966/152292) while in subpopulation NFE AF = 0.0106 (721/68010). AF 95% confidence interval is 0.00996. There are 7 homozygotes in GnomAd4. There are 439 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 7 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002617.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PEX10
NM_002617.4
MANE Select
c.318G>Ap.Leu106Leu
synonymous
Exon 3 of 6NP_002608.1O60683-1
PEX10
NM_153818.2
c.318G>Ap.Leu106Leu
synonymous
Exon 3 of 6NP_722540.1O60683-2
PEX10
NM_001374425.1
c.318G>Ap.Leu106Leu
synonymous
Exon 3 of 6NP_001361354.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PEX10
ENST00000447513.7
TSL:1 MANE Select
c.318G>Ap.Leu106Leu
synonymous
Exon 3 of 6ENSP00000407922.2O60683-1
PEX10
ENST00000288774.8
TSL:1
c.318G>Ap.Leu106Leu
synonymous
Exon 3 of 6ENSP00000288774.3O60683-2
PEX10
ENST00000874692.1
c.318G>Ap.Leu106Leu
synonymous
Exon 3 of 6ENSP00000544751.1

Frequencies

GnomAD3 genomes
AF:
0.00635
AC:
966
AN:
152174
Hom.:
7
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00224
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00334
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.00583
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0106
Gnomad OTH
AF:
0.00717
GnomAD2 exomes
AF:
0.00640
AC:
1601
AN:
250084
AF XY:
0.00615
show subpopulations
Gnomad AFR exome
AF:
0.00185
Gnomad AMR exome
AF:
0.00313
Gnomad ASJ exome
AF:
0.00359
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00619
Gnomad NFE exome
AF:
0.0109
Gnomad OTH exome
AF:
0.00590
GnomAD4 exome
AF:
0.0100
AC:
14649
AN:
1461552
Hom.:
98
Cov.:
32
AF XY:
0.00970
AC XY:
7053
AN XY:
727108
show subpopulations
African (AFR)
AF:
0.00149
AC:
50
AN:
33478
American (AMR)
AF:
0.00333
AC:
149
AN:
44700
Ashkenazi Jewish (ASJ)
AF:
0.00406
AC:
106
AN:
26110
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39690
South Asian (SAS)
AF:
0.00124
AC:
107
AN:
86254
European-Finnish (FIN)
AF:
0.00642
AC:
342
AN:
53274
Middle Eastern (MID)
AF:
0.00121
AC:
7
AN:
5766
European-Non Finnish (NFE)
AF:
0.0120
AC:
13380
AN:
1111902
Other (OTH)
AF:
0.00841
AC:
508
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
873
1747
2620
3494
4367
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00634
AC:
966
AN:
152292
Hom.:
7
Cov.:
33
AF XY:
0.00590
AC XY:
439
AN XY:
74468
show subpopulations
African (AFR)
AF:
0.00224
AC:
93
AN:
41556
American (AMR)
AF:
0.00333
AC:
51
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00165
AC:
8
AN:
4834
European-Finnish (FIN)
AF:
0.00583
AC:
62
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0106
AC:
721
AN:
68010
Other (OTH)
AF:
0.00710
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
54
108
161
215
269
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00765
Hom.:
5
Bravo
AF:
0.00621
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.00834
EpiControl
AF:
0.00931

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
1
not specified (1)
-
-
1
Peroxisome biogenesis disorder 6A (Zellweger) (1)
-
-
1
Peroxisome biogenesis disorder, complementation group 7 (1)
-
-
1
Zellweger spectrum disorders (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.57
CADD
Benign
6.7
DANN
Benign
0.84
PhyloP100
0.095
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146452560; hg19: chr1-2340173; COSMIC: COSV56580136; COSMIC: COSV56580136; API